Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Single-Arm, Open-Label Study Of The Repeated Administration Of QUTENZA For The Treatment Of Peripheral Neuropathic Pain

NCT01252160 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01252160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01252160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Single-Arm, Open-Label Study Of The Repeated Administration Of QUTENZA For The Treatment Of Peripheral Neuropathic Pain
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
October 28, 2010
Completion date
September 26, 2013
Enrollment
306 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

neuralgia, postherpetic